Myomo (NYSEAMERICAN:MYO) Stock Rating Upgraded by Zacks Inve

Myomo (NYSEAMERICAN:MYO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops […]

Related Keywords

United States , Cambridge , Cambridgeshire , United Kingdom , Massachusetts , Thomson Reuter , Northern Trust Corp , Geode Capital Management , Zacks Investment Research , Alliance Global Partners , Hsbc Holdings , Wells Fargo Company , Dimensional Fund Advisors , Myomo Inc , Get Rating , Global Partners , Trust Corp , Capital Management , Fund Advisors , Myomo , Nyseamerican Myo , Myo , Medical , Upgrade ,